(2-fluoro-6-(piperidin-4-yl)pyridin-3-yl)boronic acid
95%
- Product Code: 58137
CAS:
2225180-58-3
| Molecular Weight: | 224.0397632 g./mol | Molecular Formula: | C₁₀H₁₄BFN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃, sealed and dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the synthesis of complex molecules. It serves as a key intermediate in the creation of biologically active compounds, especially those targeting neurological disorders and cancers. Its boronic acid group facilitates Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds essential for constructing diverse pharmaceutical agents. Additionally, the piperidine moiety enhances the compound's ability to interact with biological targets, making it valuable in the design of receptor-specific drugs. Its fluorine atom further contributes to metabolic stability and binding affinity, enhancing its efficacy in therapeutic applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿47,800.00 |
+
-
|
| 0.025 | 10-20 days | ฿133,300.00 |
+
-
|
(2-fluoro-6-(piperidin-4-yl)pyridin-3-yl)boronic acid
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the synthesis of complex molecules. It serves as a key intermediate in the creation of biologically active compounds, especially those targeting neurological disorders and cancers. Its boronic acid group facilitates Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds essential for constructing diverse pharmaceutical agents. Additionally, the piperidine moiety enhances the compound's ability to interact with biological targets, making it valuable in the design of receptor-specific drugs. Its fluorine atom further contributes to metabolic stability and binding affinity, enhancing its efficacy in therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :